Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations

By sjmartinez • December 9, 2024

Seo YJ, Huston-Paterson HH, Schumm MA, Longstaff XR, Hughes EG, Tseng CH, Cheung DS, Yeh MW, Wu JX, Livhits MJ. Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations. Endocr Pract. 2024 Dec 6:S1530-891X(24)00857-7. doi: 10.1016/j.eprac.2024.12.001. Epub ahead of print. PMID: 39647526.

Tags: BRAF V600E, Endocrinology, General Internal Medicine, molecular testing, Publications, RAS, recurrence, thyroid cancer

Workshop Report-Heterogeneity and Successful Aging Part II: Approaches to Investigate Heterogeneity in Aging Research

Kumar V, Hevener AL, Ruby JG, Sebastiani P, Kuchel GA; Participants of the NIA Heterogeneity and Successful Aging Workshop. Workshop Report-Heterogeneity and Successful Aging Part[...]

Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre

Ruhle B, Kim NE, Ngo S, Hughes EG, Sajed DP, Yu R, Wu JX, Yeh MW, Livhits MJ. Genetic Testing Referral Rates for Pheochromocytoma and[...]

Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) in Kidney Transplant Recipients With Diabetes

Zelada H, Campana M, Kawai K, Redden D, Agarwal G, Gutierrez OM, Kumar V. Efficacy, Tolerability, and Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA)[...]